Pancreas Transplantation
11
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation
Pre-operative Evaluation of Kidney & Pancreas Transplant Patients
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
The Norwegian Pancreas Transplantation (PTx) Study
GDT Vs ST for Pancreas Transplant Surgery
A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids
CEUS in Kidney and Pancreas Transplantation
Insulin Secretory Capacity in Insulin-independent Pancreas-Kidney Recipients Compared to Controls
MR-Evaluation of Renal Function-After-Pancreas-transplantation
Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants
Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation